Clinical Trial Results:
A phase IV, open-label, partial cross-over partial parallel, randomized, multi-centre study to compare the gastrointestinal tolerability of once daily oral deferasirox, when administered before or after food in patients with transfusional haemosiderosis.
Summary
|
|
EudraCT number |
2010-023217-61 |
Trial protocol |
GB |
Global completion date |
03 Oct 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Dec 2018
|
First version publication date |
01 Dec 2018
|
Other versions |
|
Summary report(s) |
No patients enrolled |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.